ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Chemo, Radiation Improves DFS In Head & Neck Cancer

May 28, 2004

In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS

July 3, 1987

Final Issue of ‘76

December 10, 1976

Mandates Not welcome In Steady State Funding, Varmus Tells Senate

March 15, 1996

ASCO Honors Holland, Koop, Monaco With Special Awards

June 11, 1993

FDA Proposal To Regulate Tobacco Wins Support Of NCI, Oncology Societies

September 8, 1995